Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (171-180 of 340) with videos related to

Pageof 34
Sort By:
United European Gastroenterology Journal|May 16, 2024
The degree of bowel remission predicts phenotype progression in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Inflammatory Bowel Diseases|June 16, 2017
Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence?Susana Lopes, Patricia Andrade, Silvia Conde, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2024
Network Meta-Analysis: Histologic and Histo-Endoscopic Improvement and Remission With Advanced Therapy in Ulcerative ColitisMaria Manuela Estevinho, Bernardo Sousa-Pinto, Paula Leão Moreira, et al.
Digestive Diseases (Basel, Switzerland)|July 4, 2018
Quality of Care in Ulcerative Colitis: A Modified Delphi Panel ApproachLaurent Peyrin-Biroulet, Daniel C Baumgart, Alessandro Armuzzi, et al.
Medical Microbiology and Immunology|February 23, 2015
Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatmentNair Nazareth, Fernando Magro, Rui Appelberg, et al.
Journal of Gastroenterology and Hepatology|July 5, 2024
Angiotensin-converting enzymes 1 and 2 in the feces: presence and catalytic activity in the rat 2,4,6-trinitrobenzene sulfonic acid-induced model of colitisMariana Ferreira-Duarte, Lilian Caroline Gonçalves Oliveira, Clara Quintas, et al.
Journal of Crohn'S & Colitis|January 22, 2026
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinibFernando Magro, Gerhard Rogler, Brian G Feagan, et al.
International Journal of Colorectal Disease|November 21, 2015
Refractory monogenic Crohn's disease due to X-linked inhibitor of apoptosis deficiencyRosa Coelho, Armando Peixoto, Jorge Amil-Dias, et al.
Journal of Crohn'S & Colitis|April 14, 2023
Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial ProgrammesFernando Magro, Rish K Pai, Taku Kobayashi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 29, 2020
Prospective study of blood viral load of Epstein-Barr virus, herpes virus type 6 and human parvovirus B19 in Crohn's disease: Does therapy matter?Cândida Abreu, Pedro Palma, Beatriz Prista-Leão, et al.
Pageof 34

Showing results (171-180 of 340) with videos related to

Sort By:
Pageof 34
United European Gastroenterology Journal|May 16, 2024
The degree of bowel remission predicts phenotype progression in Crohn's diseaseSamuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva, et al.
Inflammatory Bowel Diseases|June 16, 2017
Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence?Susana Lopes, Patricia Andrade, Silvia Conde, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2024
Network Meta-Analysis: Histologic and Histo-Endoscopic Improvement and Remission With Advanced Therapy in Ulcerative ColitisMaria Manuela Estevinho, Bernardo Sousa-Pinto, Paula Leão Moreira, et al.
Digestive Diseases (Basel, Switzerland)|July 4, 2018
Quality of Care in Ulcerative Colitis: A Modified Delphi Panel ApproachLaurent Peyrin-Biroulet, Daniel C Baumgart, Alessandro Armuzzi, et al.
Medical Microbiology and Immunology|February 23, 2015
Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatmentNair Nazareth, Fernando Magro, Rui Appelberg, et al.
Journal of Gastroenterology and Hepatology|July 5, 2024
Angiotensin-converting enzymes 1 and 2 in the feces: presence and catalytic activity in the rat 2,4,6-trinitrobenzene sulfonic acid-induced model of colitisMariana Ferreira-Duarte, Lilian Caroline Gonçalves Oliveira, Clara Quintas, et al.
Journal of Crohn'S & Colitis|January 22, 2026
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinibFernando Magro, Gerhard Rogler, Brian G Feagan, et al.
International Journal of Colorectal Disease|November 21, 2015
Refractory monogenic Crohn's disease due to X-linked inhibitor of apoptosis deficiencyRosa Coelho, Armando Peixoto, Jorge Amil-Dias, et al.
Journal of Crohn'S & Colitis|April 14, 2023
Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial ProgrammesFernando Magro, Rish K Pai, Taku Kobayashi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 29, 2020
Prospective study of blood viral load of Epstein-Barr virus, herpes virus type 6 and human parvovirus B19 in Crohn's disease: Does therapy matter?Cândida Abreu, Pedro Palma, Beatriz Prista-Leão, et al.
Pageof 34